Buy OTLK by Sep 30, 2026.

If you’re looking for a high potential biotech stock that recently got their resubmit of their trial approve by the FDA. Look at OTLK. Trial has already been approved in Europe and more than likely going to be approved by the FDA. They set a date on the approval response BY July 29th. Stock has already had a bit of a run up and profit taking but still trading way under what it would be if they get approved.